Remove 2020 Remove Healthcare Provider Remove Prescription
article thumbnail

Value-based healthcare can help reduce costs

World of DTC Marketing

health insurers report billions as small providers face stress in the first quarter. The nation’s largest health insurer, UnitedHealth Group, reported $4.9bn in profits in the first quarter of 2021 compared to $3.4bn in the same period in 2020 – a 44% increase. The answer may be in offering a value-based healthcare model.

article thumbnail

Improving Patient Portal Engagement with Pharma Content

PM360

Following the impact of the COVID pandemic in 2020, patient engagement has become the focus area for more than half of healthcare chief information officers (CIOs). Healthcare professionals are in great need of quality educational materials, yet it can seem like most pharmaceutical companies prefer running ads instead.

Pharma 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How COVID-19 Has—and Will Continue to—Transform the Pharmacy

PM360

Adding responsibilities of testing for COVID-19 and administering the vaccine in mass volumes when it became available, pharmacists and techs had to shuffle workload and priorities in a way that supported this critical role as healthcare providers. Given the convenience of the local pharmacy to most in the U.S.,

Retail 98
article thumbnail

8 Ways to Enhance the Patient Experience & Drive Leads with QR Codes

Healthcare Success

We know that today’s healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . Prescription refills. Patient verification. Elderly care.

Leads 109
article thumbnail

Understanding a rare disease through the lens of real world and prevalence data

Clarivate

Our analysis included prescription trends for antibiotics, steroids, vitamins and ophthalmic-intraocular pressure reducing agents (prostaglandin analogs and alpha-adrenergic agonists) from 2018 to 2021. 4; 4/20/2020; DOI:10.7759/cureus.7745 ” Molecular Vision; 12/28/2020; p789 [5] Sahel J et al. ” Cureus; V.12;

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

Survival of the fittest: Biotech reset “Horrible” and “carnage” were how some described the early 2022 environment for biotech financing, as funding fell significantly below the highs of 2020 and 2021, and IPOs all but dried up. A longer historic view of biotech funding, however, reverses the picture: 2020 and 2021 were not normal years.

article thumbnail

What health plans should know about healthcare price transparency

Clarify Health

The No Surprises Act and Transparency in Coverage Rule The past two years have been monumental for healthcare transparency and reporting regulations. The No Surprises Act (NSA), signed into law in December 2020, and the Transparency in Coverage Rule (TiC), published in October 2020, will have significant implications for health plans in 2022.